Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.785
+0.005 (0.63%)
At close: Apr 28, 2026, 4:00 PM EDT
0.782
-0.003 (-0.42%)
After-hours: Apr 28, 2026, 5:36 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $8.31 million as of April 28, 2026. Its market cap has decreased by -8.96% in one year.
Market Cap
8.31M
Enterprise Value
9.71M
1-Year Change
-8.96%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $8.31M, a decrease of -70.34%. That is a compound annual growth rate of -6.34%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 11.25M |
| Imunon | 10.94M |
| Aprea Therapeutics | 10.65M |
| Kiora Pharmaceuticals | 10.31M |
| Quoin Pharmaceuticals | 10.28M |
| Enveric Biosciences | 10.01M |
| GT Biopharma | 9.86M |
| Genprex | 9.39M |